193 related articles for article (PubMed ID: 28652542)
1. Therapeutic potential of ghrelin and des-acyl ghrelin against chemotherapy-induced cardiotoxicity.
Nonaka M; Kurebayashi N; Murayama T; Sugihara M; Terawaki K; Shiraishi S; Miyano K; Hosoda H; Kishida S; Kangawa K; Sakurai T; Uezono Y
Endocr J; 2017; 64(Suppl.):S35-S39. PubMed ID: 28652542
[TBL] [Abstract][Full Text] [Related]
2. Salmon acyl-ghrelin increases food intake and reduces doxorubicin-induced myocardial apoptosis in rats, likely by anti-oxidative activity.
Kihara M; Kaiya H; Hirai Y; Katayama H; Terao A; Nishikawa M
Peptides; 2021 Mar; 137():170471. PubMed ID: 33340558
[TBL] [Abstract][Full Text] [Related]
3. Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.
Xue H; Ren W; Denkinger M; Schlotzer E; Wischmeyer PE
JPEN J Parenter Enteral Nutr; 2016 Jan; 40(1):52-66. PubMed ID: 25888676
[TBL] [Abstract][Full Text] [Related]
4. Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
Sarfraz M; Afzal A; Raza SM; Bashir S; Madni A; Khan MW; Ma X; Xiang G
Oncotarget; 2017 Jul; 8(29):47136-47153. PubMed ID: 28525367
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity.
Abushouk AI; Ismail A; Salem AMA; Afifi AM; Abdel-Daim MM
Biomed Pharmacother; 2017 Jun; 90():935-946. PubMed ID: 28460429
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
7. A herbal formula, SYKT, reverses doxorubicin‑induced myelosuppression and cardiotoxicity by inhibiting ROS‑mediated apoptosis.
Chen T; Shen HM; Deng ZY; Yang ZZ; Zhao RL; Wang L; Feng ZP; Liu C; Li WH; Liu ZJ
Mol Med Rep; 2017 Apr; 15(4):2057-2066. PubMed ID: 28260045
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity.
Shoukry HS; Ammar HI; Rashed LA; Zikri MB; Shamaa AA; Abou Elfadl SG; Rub EA; Saravanan S; Dhingra S
PLoS One; 2017; 12(7):e0181535. PubMed ID: 28727797
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells.
Lee DH; Kim S; Nam KS
Int J Oncol; 2014 Dec; 45(6):2569-75. PubMed ID: 25270851
[TBL] [Abstract][Full Text] [Related]
10. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
Koleini N; Kardami E
Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
[TBL] [Abstract][Full Text] [Related]
11. Effect of ghrelin on VEGF-B and connexin-43 in a rat model of doxorubicin-induced cardiomyopathy.
Elhadidy MG; Elmasry A; Rabei MR; Eladel AE
J Basic Clin Physiol Pharmacol; 2019 Nov; 31(1):. PubMed ID: 31730522
[TBL] [Abstract][Full Text] [Related]
12. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.
Robinson P; Kasembeli M; Bharadwaj U; Engineer N; Eckols KT; Tweardy DJ
Biomed Res Int; 2016; 2016():1959270. PubMed ID: 26981525
[TBL] [Abstract][Full Text] [Related]
13. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
[TBL] [Abstract][Full Text] [Related]
15. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Cote B; Carlson LJ; Rao DA; Alani AWG
J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: Insight by LC-MS based non-targeted metabolomic analysis.
Yi X; Zhu J; Zhang J; Gao Y; Chen Z; Lu S; Cai Z; Hong Y; Wu Y
J Pharm Biomed Anal; 2018 Apr; 152():264-270. PubMed ID: 29438868
[TBL] [Abstract][Full Text] [Related]
18. Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.
Zheng K; Li R; Zhou X; Hu P; Zhang Y; Huang Y; Chen Z; Huang M
Int J Nanomedicine; 2015; 10():5327-42. PubMed ID: 26346331
[TBL] [Abstract][Full Text] [Related]
19. Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway.
Pei XM; Yung BY; Yip SP; Ying M; Benzie IF; Siu PM
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E311-23. PubMed ID: 24326424
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.
Carvalho FS; Burgeiro A; Garcia R; Moreno AJ; Carvalho RA; Oliveira PJ
Med Res Rev; 2014 Jan; 34(1):106-35. PubMed ID: 23494977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
